Joseph Pergolizzi

Summary

Country: USA

Publications

  1. doi request reprint Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 11:230-9. 2011
  2. pmc The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 29:1127-35. 2013
  3. pmc Pain after earthquake
    Chiara Angeletti
    Anaesthesiology, Intensive Care and Pain Medicine, Department of Health Sciences, University of L Aquila, L Aquila, Italy
    Scand J Trauma Resusc Emerg Med 20:43. 2012
  4. doi request reprint Compounding pharmacies: who is in charge?
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 13:253-7. 2013
  5. doi request reprint Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
    J Clin Anesth 24:334-45. 2012
  6. doi request reprint Current considerations for the treatment of severe chronic pain: the potential for tapentadol
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:290-306. 2012
  7. doi request reprint Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:159-73. 2012
  8. doi request reprint The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 28:249-56. 2012
  9. doi request reprint Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:33-44. 2012
  10. doi request reprint Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:45-56. 2012

Collaborators

Detail Information

Publications23

  1. doi request reprint Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 11:230-9. 2011
    ....
  2. pmc The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 29:1127-35. 2013
    ..Improved training in pain management is clearly needed, starting with the undergraduate medical curriculum, and this review is intended to encourage further study by those who manage patients with chronic pain...
  3. pmc Pain after earthquake
    Chiara Angeletti
    Anaesthesiology, Intensive Care and Pain Medicine, Department of Health Sciences, University of L Aquila, L Aquila, Italy
    Scand J Trauma Resusc Emerg Med 20:43. 2012
    ..The earthquake caused 308 casualties and over 1,500 injuries, displaced more than 25,000 people and induced significant damage to more than 10,000 buildings in the L'Aquila region...
  4. doi request reprint Compounding pharmacies: who is in charge?
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 13:253-7. 2013
    ..Moreover, clinicians should be better aware that some injectable products they use may have been prepared by a compounding pharmacy...
  5. doi request reprint Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
    J Clin Anesth 24:334-45. 2012
    ..59, 95% CI, 0.48-0.73, P < 0.001), postoperative vomiting (RR=0.68, 95% CI, 0.61-0.76, P < 0.001), and PONV (RR 0.73, 95% CI, 0.60-0.88, P = 001) in the first 24 hours after the start of anesthesia...
  6. doi request reprint Current considerations for the treatment of severe chronic pain: the potential for tapentadol
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:290-306. 2012
    ..Pain relief remained stable throughout a 1-year safety study. Thus, tapentadol could possibly overcome some of the limitations of currently available analgesics for the treatment of chronic pain...
  7. doi request reprint Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:159-73. 2012
    ..For postsurgical analgesia with any acetaminophen product, patient education is necessary to be sure that the patient does not concurrently take any over-the-counter products containing acetaminophen and accidentally exceed dose limits...
  8. doi request reprint The chronic pain conundrum: should we CHANGE from relying on past history to assessing prognostic factors?
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 28:249-56. 2012
    ..Despite limited empirical support, chronic pain has traditionally been defined mainly on the basis of its duration, which takes no account of the causative mechanisms or its clinical significance...
  9. doi request reprint Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:33-44. 2012
    ....
  10. doi request reprint Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:45-56. 2012
    ..Patients in the study who experienced DDEs that placed them at risk for PK DDIs had significantly greater utilization rates of healthcare resources and higher associated payments in the 6-month observation period following exposure...
  11. pmc Restoration of disk height through non-surgical spinal decompression is associated with decreased discogenic low back pain: a retrospective cohort study
    Christian C Apfel
    Perioperative Clinical Research Core, Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA
    BMC Musculoskelet Disord 11:155. 2010
    ....
  12. ncbi request reprint Quantifying the impact of drug-drug interactions associated with opioids
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Manag Care 17:S288-92. 2011
    ..Clinicians often underestimate the risk of DDIs in patients using opioids. Comprehensive studies of real-world opioid utilization patterns are needed to determine the quantitative impact of opioid DDIs...
  13. doi request reprint Extended-release formulations of tramadol in the treatment of chronic pain
    Joseph V Pergolizzi
    Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD, USA
    Expert Opin Pharmacother 12:1757-68. 2011
    ....
  14. doi request reprint Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, met
    Joseph Pergolizzi
    Johns Hopkins University, Baltimore, Maryland, USA
    Pain Pract 8:287-313. 2008
    ..Slow dose titration helps to reduce the incidence of typical initial adverse events such as nausea and vomiting. Sustained release preparations, including transdermal formulations, increase patient compliance...
  15. doi request reprint The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus
    Joseph V Pergolizzi
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 25:1517-28. 2009
    ....
  16. doi request reprint Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes
    Joseph V Pergolizzi
    Johns Hopkins University, Baltimore, Maryland, USA
    Pain Pract 10:201-13. 2010
    ..Several clinical trials of this oil will be reviewed...
  17. doi request reprint The role of urine drug testing for patients on opioid therapy
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Pain Pract 10:497-507. 2010
    ..The study found motivations for urine testing and testing practices varied widely, and urine testing, despite its clinical utility, is not used consistently...
  18. doi request reprint Current knowledge of buprenorphine and its unique pharmacological profile
    Joseph Pergolizzi
    Johns Hopkins University, Baltimore, Maryland, USA
    Pain Pract 10:428-50. 2010
    ..The expert group agreed that these properties, as well as proven efficacy in severe pain and favorable tolerability, mean that buprenorphine can be considered a safe and effective option for treating chronic cancer and noncancer pain...
  19. doi request reprint Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 11:325-36. 2011
    ..When selecting an opioid analgesic to treat osteoarthritis, physicians should consider the potential for exposure of these patients to drugs that could interact unfavorably. ..
  20. doi request reprint The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization
    Paul Langley
    College of Pharmacy, University of Minnesota, Minnesota, MN 55455 0343, USA
    J Med Econ 13:571-81. 2010
    ..This paper reports on the results of a series of quantitative assessments of the association of severe and frequent pain with health-related quality of life and healthcare resource utilization in five European countries...
  21. doi request reprint The impact of pain on labor force participation, absenteeism and presenteeism in the European Union
    Paul Langley
    College of Pharmacy, University of Minnesota, Minnesota, MN 55455 0343, USA
    J Med Econ 13:662-72. 2010
    ....
  22. pmc Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
    Joseph Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Pain Res 4:203-10. 2011
    ..Current evidence indicates that tapentadol's efficacy/tolerability ratio may be better than those of classical opioids. However, further research is needed to establish its role in pain management...
  23. doi request reprint Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study
    Aron Altorjay
    Department of Surgery, St George University Teaching Hospital, Szekesfehervar, Hungary
    Arch Surg 146:201-6. 2011
    ....